A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight
Clinical trial NCT04657003 · COMPLETED
Trial details
- NCT number
- NCT04657003
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-29
- Primary completion
- 2023-03-16
- Enrollment
- 938
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.